Belize vs Egypt: Estimated antiretroviral therapy coverage among people living with HIV
Belize
47.0%
in 2025
Egypt
48.0%
in 2025
Belize rank
129th
Egypt rank
127th
Estimated antiretroviral therapy coverage among people living with HIV over time
- Belize
- Egypt
How they compare
Egypt currently reports 48.0% against 47.0% in Belize, a difference of 1.0%.
The two have swapped places 1 time across 26 shared years of data; in 2000 it was Belize ahead.
Belize ranks 129th and Egypt ranks 127th of 143 countries.
Belize has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Belize | Egypt | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 10.7% | 0.6% | 10.1% | Belize |
| 2010s | 29.8% | 9.7% | 20.1% | Belize |
| 2020s | 41.8% | 36.2% | 5.7% | Belize |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Belize or Egypt?
- Egypt, at 48.0% against 47.0% in Belize as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Belize and Egypt?
- 1.0%, with Egypt ahead.
- How many years of comparable data are there for Belize and Egypt?
- 26 years are reported by both, from 2000 to 2025.
- How do Belize and Egypt rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Belize ranks 129th and Egypt ranks 127th of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.